The Uttar Pradesh government is set to host a landmark event titled "Pharma Conclave 1.0: Investment Opportunities in Uttar Pradesh" on February 3 at the prestigious Hotel Taj in Lucknow. This significant gathering is being jointly organized by the Uttar Pradesh Food Safety and Drug Administration (FSDA) and Invest UP, marking a strategic push to boost the state's healthcare and industrial sectors.
High-Profile Inauguration and Participation
Uttar Pradesh Chief Minister Yogi Adityanath will inaugurate the conclave, lending his support to this crucial initiative. Adding to the event's prominence, Union Health Minister JP Nadda will address the attendees through a video message, highlighting the national importance of pharmaceutical advancements. Deputy Chief Minister Brajesh Pathak, along with several cabinet and state ministers, will also be present, underscoring the government's commitment to fostering growth in this domain.
Objectives and Focus Areas
According to Dr. Roshan Jacob, Secretary and Commissioner of FSDA, the conclave aims to delve into investment opportunities within Uttar Pradesh's pharmaceuticals and medical devices sector. The discussions will center on key areas such as manufacturing, research, and innovation, with a goal to attract both domestic and international investors. This aligns with the state's broader economic development strategies.
Industry Leaders and Representatives
The event will witness participation from senior representatives of leading pharmaceutical companies, including notable figures like Ayodhya Rami Reddy from Ramco Group, Dilip Shanghvi of Sun Pharma, Ramesh Juneja from Mankind Pharma, Dr. Satish Reddy of Dr. Reddy’s Laboratories, Pankaj R Patel from Zydus Lifesciences, and Ginal Mehta of Torrent Pharmaceuticals. Executives from other major firms such as MSN Laboratories, Dabur, and Alkem are also expected to join, making it a comprehensive industry gathering.
Support from Industry Bodies
The conclave is being supported by prominent industry bodies, including the Indian Pharmaceutical Alliance (IPA), Indian Drug Manufacturers’ Association (IDMA), Bulk Drug Manufacturers Association of India (BDMAI), Organisation of Pharmaceutical Producers of India (OPPI), and the Federation of Pharma Entrepreneurs (FOPE). This collaboration ensures a well-rounded perspective on the sector's needs and opportunities.
Key Discussion Topics
Discussions at the event will cover a range of critical topics, such as the policy framework for pharmaceuticals and medical devices, incentives available under the Uttar Pradesh Pharmaceutical and Medical Device Industry Policy 2023, and updates on proposed projects. Notable projects on the agenda include the Bulk Drug Park in Lalitpur and the Medical Device Park in Greater Noida, which are poised to enhance the state's infrastructure and attract further investments.
Overall, the Pharma Conclave 1.0 represents a significant step by the Uttar Pradesh government to position the state as a hub for pharmaceutical and medical device innovation, leveraging its strategic location and policy support to drive economic growth and healthcare advancements.
